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ABSTRACT 
Background: Lung cancer is the major cause of death worldwide including Indonesia 
especially nonsmall cell lung cancer (NSCLC) group includingadenocarcinoma, squamus 
carcinoma (SqCCA) and large cell lung cancer (LCLC).Incidence of lung 
adenocarcinoma continues to rise up about 40% of all NSCLC in January 2012- 
Desember 2013;  and 15% of pleural effusion associated with malignancies. To confirm 
the diagnosis, monoclonal antibody anti -TTF-1 and CK-7 are currently used to identify 
types of lung tumors adenocarcinoma , especially  when cytomorfologically is doubtful. 
Methods: The design of the study wasa descriptive observational, that included 
individuals who were hospitalized at Dr. Kariadi TeachingHospital in Semarang, 
confirmed by  thorax X-ray with diagnosis of suspected lung malignancy, between 
January 2012 – 2013. The expression of TTF-1 and CK-7 Were analysed using 
immunohistochemistry.  
Result: A total of 20 samples subjected to Pearson correlation test with result of p 
value = < 0,001 and r = 0,867. The highest expression TTF-1 in the all study sample 
wasadenocarcinoma (73.3%) and highest expression CK-7 was also adenocarcinoma 
(68.6%). 
Conclusion:The expressionof TTF-1 and CK-7 on tissue samples can be used to 
confirmadenocarcinoma malignancy on the cytological sample of suspected malignant 
pleural effusion  
Keywords: TT-1, CK-7, adenocarcinoma, pleural effusion, nonsmall cell lung cancer 
(NSCLC) 
 
INTRODUCTION  
 Lung cancer is a major cause of death in the world, 
including Indonesia, especially non-small cell lung 
cancer (NSCLC) including adenocarcinoma, squamous 
carcinoma (SqCCA) and large cell lung cancer (LCLC) 
that occurs in about 80% of all lung cancer. 
1,2  
Recently, 
the incidence rate of lung adenocarcinoma  is 
increasingabout 40% ofall non-small cell lung cancer 
(NSCLC).
3
 Lung cancer in Indonesia was ranked fourth 
of all cancers, Data fromMinistry of Health shows the 
number of cancer cases  in Indonesia reached to  6% of 
the population. 
4,5
 
  
 
 Pleura effusion is a condition where there is an 
excessive fluid in the pleural cavity, 15% of the cases 
are associated with malignancy provenby the presence 
of malignant cells in cytological examination from 
pleural effusion or biopsyof the lung. This malignancy 
could be categorized intoadenocarcinoma, squamous 
cell carcinoma, small cell carcinoma, mesothelioma 
malignancy, neuroendocrin tumor.
6,7 
The expresions of 
TTF-1 and CK-7 antibodiesare used to differentiate 
between adenocarcinoma with other carcinoma.TTF-1 
and CK-7 are available in the market and relatively 
inexpensive. Yue-Chiu Su (2006) showed that TTF-1  
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antibody and CK-7 can differentiate adenocarcinoma 
lung primer and metastatic. TTF-1 is a sensitive marker 
for pulmonary and thyroid adenocarcinoma. TTF-1 
immunohistochemistry is a very sensitive and highly 
specific method in the differential diagnosis of primary 
and metastatic lung adenocarcinomas and should be 
used in the everyday clinical practice.
8,9,10
 
 The examination by immunocytochemistry staining 
for Thyroid transcription factor-1 (TTF-1), Cytokeratin 
7 (CK 7), Cytokeratin 20 (CK 20), are important to 
differentiate among those type of cancers (Kingshuk R 
et al, 2013) 
8,9
. 
 This study using a cytology block of pleural 
effusion. To diagnosemalignant cells in the cytology 
preparations sometimes difficult to distinguish between 
the benign and malignant cells, lead to misdiagnosis. 
Therefore, the usage of TTF-1 and CK-7 antibodies to 
identify types of lung adenocarcinoma is very useful to 
determine whether the cells are malignant or not.This 
research usingTTF-1 and CK-7 monoclonal antibody to 
differentiate specifically between adenocarcinoma with 
other carcinoma, without increasing cost of 
examination.  
 
METHODS  
 This study was a cross sectional design. This study 
population included individuals admitted to the 
Dr.Kariadi TeachingHospital in Semarang that had been 
thorax X-ray with diagnosis of suspected malignant 
pleural effusion. Cytological examination of Pleural 
effusion  performed  using immunohostochemistry 
method. The number of research sample were 
consecutive population who met the inclusion criteria. 
The Expression of TTF-1 positive was brown staining at 
the  nuclei where as CK7 positive was brown staining in 
the cytoplasm, the color intensity and percentage are 
calculated using Allred Score 
8
.
 
All met  inclusion 
criteria patients had  to sign an informed consent form 
to approve their participation, and the research proposal 
have been approved by The Ethical Review Board of 
the Institution .  
 
RESULT AND DISCUSSION  
 A total of  20 samples with suspected malignant 
pleural effusion met the inclusion criteria were included 
in this study. 
Table 1. Descriptive Diagnosis of TTF-1 and CK-7 in 
20 patients. 
 Table 1 shows the expression of TTF-1 maximum 
value on sample of suspected adenocarcinoma with 
score 7, while minimum value on sample of suspected 
squamos cell carcinoma with score 0. Whereas CK-7 
shows maximum value on sample of suspected 
adenocarcinoma with score 8, while  minimum value on 
squamos cell carcinoma with score 0. 
 
 
Table 2.   Pearson Correlation Test Result  
Variable Mean  SD R P 
TTF-1 3.85  2.254 
0.867 < 0.001* 
CK-7 4.45  2.460 
 
 Table2. shows Pearson correlation p value = < 0.001 
and r = 0.867, so we conclude that there is a significant 
relationship between expressions of TTF-1 to CK-7 
with very strong power of positive relationship  
 
 
Table 3. Percentage TTF-1 and CK-7 
  
 
 
Diagnosis n Mean SD Median Min Max 
TTF-1 Suspected Adenocarcinoma 11 5.55 1.036 6.00 4 7 
 Suspected Adenosquamus cell  carcinoma 3 2.67 0.577 3.00 2 3 
 Suspected Squamus cell carcinoma 6 1.33 1.506 1.00 0 3 
CK-7 Suspected Adenocarcinoma 11 6.00 1.096 6.00 4 8 
 Suspected Adenosquamus cell  carcinoma 3 4.67 2.082 4.00 3 7 
 Suspected Squamus cell carcinoma 6 1.50 1.761 1.00 0 4 
Diagnosis 
TTF-1 
p Positive Negative 
n % n % 
Suspected 
Adenocarcinoma 
11 73.3 0 0 0.009 
Suspected 
Adenosquamus cell  
carcinoma 
2 14.4 1 20  
Suspected Squamus cell 
carcinoma 
2 12.3 4 80  
Diagnosis 
CK-7 
P Positive Negative 
n % n % 
Suspected Adenocarcinoma 11 68.8 0 0 0.003 
Suspected Adenosquamus cell  
carcinoma 
3 18.8 0 0  
Suspected Squamus cell 
carcinoma 
2 12.5 4 100  
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On Table 3, result of percentage expression of TTF-1 in 
all sample was highest on suspected positive 
adenocarcinoma was 73.3% and lowest was on sample 
of suspected squamus cell carcinoma of 12.3%. While 
percentage of expression of CK-7 in all sample was 
highest on suspected positive adenocarcinoma of 68.8 % 
and lowest on sample of suspected squamus cell 
carcinoma of 12.5 %. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Malignant cell stained TTF-1 positive, brown 
staining on the core of malignant cell(arrow) 
 
 
 
 
Figure 1.The expression of TTF-1 and CK-7 in all 
patients (in percentage). 
 
 The graphs show the expression of  TTF-1 and CK-7 
are dominant in  patients with suspected lung 
adenocarcinoma,  meanwhile less expressed  in 
patients suspected lung squamous cell carcinoma. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Malignant cell  in Haematoxylin Eosin and 
Pappanicolau stained 
 
 
 
 
   
 
 
 
 
Figure 4. Microscopic staining of CK-7 Positive, arrow 
showed cell stained CK-7 positive, brown staining on 
the cytoplasm of malignant cell (arrow) 
 
 Lung cancer is the leading cause of death 
worldwide. WHO classification of 2004, there are seven 
main histological types of lung tumors epithelial 
malignancy and over 20 variants. Lung epithelial tumor 
of non-small cell lung carcinoma, includes: 
adenocarcinoma, squamous cell carcinoma, large cell 
and large cell undifferentiated carcinoma.
13
 Several 
studies have shown a tendency of adenocarcinoma type 
to metastasize faster, and its incidence continues to 
increase. Adenocarcinoma are found mainly in Asian 
women (72% of cancer cases in Japan, 65% in Korea, 
61% in China Singapore). The differences in 
A. Magnification 100X, 
Haematoxylin Eosin , 
shows group of cancer 
cell    (arrow) 
 
 
B. Magnification 200X, 
Pappanicolaou stain , 
shows group of cancer 
cell    (arrow) 
 
 
A. Magnification100X, 
CK-7 staining 
B. Magnification 400X, 
CK-7 staining 
C. Magnification 100X, 
CK-7 staining 
D. Magnification400X, 
CK-7 staining 
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histological types are mostly affected  by variations of 
smoking habits, while in United States the incidence of 
adenocarcinoma of the lung is 38% of all lung cancers. 
11,12,13
 
 Table 3 shows the expression of TTF-1 in the 
sample suspected adenocarcinoma was 73.3% in the 
sample suspected squamous cell carcinoma was 13.3%, 
whereas, the expression of CK-7suspected 
adenocarcinoma showed 68.8% and in the sample of 
squamous cell carcinoma was 12.5%. the results 
indicateing that the expression of TTF-1  and CK-7 are 
more dominant on suspected adenocarcinoma than the 
other. This results is almost the same with the previous 
study on the expression of TTF-1 and CK-7, by Yue-
Chiu Su (2006), They found that TTF-1 antibody and 
CK-7 can be used to differentiate adenocarcinoma lung 
primer and metastatic
14,15
. 
 Primary lung malignancy contain Surfactant protein 
A (SPA) which is a major component of surfactant and 
Clara cell, which is synthesized and excreted in the lung 
alveoli by type II pneumocyte. In pleural effusion 
caused by primary lung malignancy, it contains high 
concentration of Surfactant protein A (SPA) especially 
in lung adenocarcinoma, that then will express TTF-1. 
Evidences indicated that TTF-1 is very important in the 
development of lung embryogenesis and increased 
expression in Clara cells and type II pneumocyte.
15,16
 
 In this study , the expression of TTF-1 in 
adenocarcinoma was 73.3%, adenosquamus14.4%, 
while the squamus cell carcinoma contain a little 
Surfactant protein A (SPA) so that in this study the 
expression is only 12.2%. According to the previous 
studies,  TTF-1 expressing specific tissue indicating  the 
specific molecular biomarkers in primary tumors of lung 
adenocarcinoma.
13
 
 In the group of CK-7 the most dominant expression 
was in the samples of suspected lung adenocarcinoma 
by 68.8% Cytokeratin-7 (CK7) is a human protein that 
encodes the gene KRT7, a type II keratin. Cytokeratin 7 
is a protein that mainly located in the lung and breast 
organs. In research conducted by Peiguo Chu stated that 
the expression of CK-7 in lung adenocarcinoma was 
100% while the squamous cell carcinoma of  lung was 
0% in all cases.
16
 Although CK-7 is able to identify lung 
adenocarcinoma, but it can also be positive in the 
metastasis of other tumors. CK-7 and CK-20 are often 
combined, especially when suspected of metastases 
from colorectal tumors (intestinal tumors), in metastatic 
colorectal tumors in the lung CK-7 is negative while 
CK-20 is positive, therefore clinical examination is very 
important to predict the primary or secondary tumor.
16,17
 
 The use of antibody TTF-1 and CK-7 to identify 
types of lung tumors adenocarcinoma can be used to 
confirm a doubtful cytomorfological that can 
differentiate between  malignant or not.
18
 From the 
discussion above we can conclude that the expression of 
TTF-1 and CK-7 protein are overexpressed in samples 
of lung adenocarcinoma.
19,20
 
 
CONCLUSION 
 TTF-1 and CK-7 espressions can be used to detect 
malignancy especially lung adenocarcinoma using 
cytology preparation. The expression of TTF-1 andCK-
7 is very strong positive predictor (p≤ 0.001 and r = 
0.867) and biomarker for lung adenocarcinoma 
 
SUGGESTION 
 Using other specific antibody immune histo 
chemistry as the marker of lung adeno carcinoma is 
recommended to avoid secondary tumor 
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